BioSpace News Archive

CMS accepts Epigenomics’ application for NCD review

May 5, 2019
·
2 min read
Business

NOXXON Announces Change Within Supervisory Board

NOXXON Pharma N.V. announced the appointment of Dr. Maurizio PetitBon, member of the Supervisory Board since September 2016, as Chairman of NOXXON’s Board.

May 5, 2019
·
2 min read
Deals

Recipharm AB publishes its interim report January-March 2019

With revenue increase of 20 per cent in the first quarter we report all-time high net sales, first time over SEK 1.8 billion in a quarter.

May 5, 2019
·
5 min read
Biotech Beach

MDxHealth: Presentation of New Data for MDxHealth’s Prostate Cancer Diagnostic Tests at AUA 2019 Annual Meeting

Moderated posters feature clinical validations of SelectMDx and ConfirmMDx

May 5, 2019
·
3 min read
Deals

GeoVax Announces Reverse Stock Split

GeoVax Labs, Inc. announced it has implemented a 1-for-500 reverse stock split of its common stock with a market effective date of May 2, 2019.

May 5, 2019
·
2 min read
Fifty Countries Represented at Hong Kong Congress in a Powerful Expression of Scientific Exchange in the Field of Assisted Reproduction

More than 1,700 fertility specialists from 50 countries are attending the 9th Congress of the Asia Pacific Initiative on Reproduction in Hong Kong to explore the latest advances in scientific research and clinical care of people experiencing infertility.

May 5, 2019
·
3 min read
Drug Development

Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting

Results Confirm the Posterior Trajectory as an Additional Surgical Delivery Route for VY-AADC in Patients with Parkinson’s Disease

May 5, 2019
·
12 min read
Drug Development

UroGen Delivers Updated Complete Response (CR) and Durability Data from the UGN-101 Phase 3 OLYMPUS Trial

UroGen Pharma Ltd. announced findings from a secondary analysis from the pivotal Phase 3 OLYMPUS trial which showed that UGN-101 (mitomycin gel) for instillation, an investigational mitomycin formulation, demonstrated a 59 percent complete response rate in a subset of patients with endoscopically unresectable low-grade upper tract urothelial cancer.

May 5, 2019
·
6 min read
Amgen invites the general public to help set an official Guinness World Records™ title for the most osteoporosis screenings within 24 hours and help increase awareness about osteoporosis

Osteoporosis-Screening Events to Take Place in Ten Countries on May 5th, 2019 in Conjunction with Guinness World Records™

May 5, 2019
·
5 min read
Drug Development

Neurocrine Biosciences Presents Phase III Data Analysis Demonstrating that Opicapone Added to Levodopa Resulted in a Significant and Sustained Increase in ON Time without Troublesome Dyskinesia in Parkinson’s Disease Patients

More than 60% of Patients Treated with Once-Daily Opicapone 50 mg Experienced an Increase in Total ON Time of One Hour or Longer

May 5, 2019
·
9 min read